Quest Diagnostics Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/14/2026)
| Balance Sheet | Total Assets | 16,225,000,000.00 | ROE | 44.19 % |
| Balance Sheet | Total Equity | 7,170,000,000.00 | ROA | 6.11 % |
| Cashflow | Capital Expenditures | -527,000,000.00 | P/FCF | 19.41 |
| Cashflow | Free Cash Flow | 1,359,000,064.00 | – | – |
| Cashflow | Operating Cash Flow | 1,886,000,000.00 | P/CF | 13.99 |
| Income | Earnings per Share (diluted) | 8.75 | Div. Yield | 1.37 % |
| Income | Net Income | 992,000,000.00 | P/E | 26.68 |
| Income | Shares Outstanding | 113,000,000.00 | P/B | 3.68 |
| Income | Total Revenue | 11,035,000,000.00 | P/S | 2.39 |
Ratios calculated on: 10/14/2026
Company Description
Quest Diagnostics Incorporated (Quest Diagnostics), is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. It provides interpretive consultation through the medical and scientific staff. It is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. On September 30, 2013, it sold its Enterix colorectal cancer screening test business to Clinical Genomics Technologies Pty Ltd. In October 2013, Quest Diagnostics Incorporated acquired ConVerge Diagnostic Services, LLC from Water Street Healthcare Partners.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.questdiagnostics.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more